Rajthanee Hospital Public Company Limited

As of June 30, 2026, Rajthanee Hospital Public Company Limited NVDR carries a market capitalization of 4.02B, placing it among publicly traded companies globally. Its enterprise value stands at 5.67B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Rajthanee Hospital Public Company Limited NVDR's next confirmed earnings release is scheduled for November 9, 2026.

As of June 30, 2026, Rajthanee Hospital Public Company Limited NVDR has 293.48M shares outstanding.

As of June 30, 2026, Rajthanee Hospital Public Company Limited NVDR trades at a trailing price-to-earnings ratio of 10.80. The price-to-sales ratio is 1.37, and the price-to-book ratio stands at 1.78.

As of June 30, 2026, Rajthanee Hospital Public Company Limited NVDR trades at an EV/EBITDA multiple of 9.56 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.94 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 13.80 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 5.67B versus a market cap of 4.02B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Rajthanee Hospital Public Company Limited NVDR maintains a current ratio of 0.71, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 58.08, indicating elevated leverage, while an interest coverage ratio of 11.39 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Rajthanee Hospital Public Company Limited NVDR posted a return on equity (ROE) of 17.25, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 8.46, measuring how efficiently the asset base is converted into earnings. The company generates approximately 3.28M in revenue per employee across its workforce of 893.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 31.20 indicates how many times Rajthanee Hospital Public Company Limited NVDR sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Rajthanee Hospital Public Company Limited NVDR recorded an income tax benefit of -13.96M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 358.72M, leaving 372.15M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Rajthanee Hospital Public Company Limited NVDR's stock has gained approximately 28.46% over the past 52 weeks. The 50-day moving average sits at 15.48, while the 200-day moving average is 13.82.

Over the twelve months ended June 30, 2026, Rajthanee Hospital Public Company Limited NVDR generated 2.93B in revenue and converted that into 372.15M in net income, yielding earnings per share of 1.27. EBITDA reached 592.94M, while operating income came in at 377.52M.

As of June 30, 2026, Rajthanee Hospital Public Company Limited NVDR holds 121.04M in cash and equivalents against 1.48B in total debt, resulting in a net debt position of 1.35B. Total book value stands at 2.26B, with working capital of -361.60M providing operational flexibility.

Rajthanee Hospital Public Company Limited NVDR produced 446.53M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -137.84M in capital expenditures, free cash flow totaled 308.70M - equivalent to 1.05 per share.

Over the twelve months ended June 30, 2026, Rajthanee Hospital Public Company Limited NVDR posted a gross margin of 25.99, reflecting its pricing power and cost economics. The operating margin of 12.90 and net profit margin of 12.71 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Rajthanee Hospital Public Company Limited NVDR paid dividends of 0.60 per share. The dividend payout ratio of 47.27 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 7.68, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 7.05, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Rajthanee Hospital Public Company Limited NVDR shareholders.

As of June 30, 2026, Rajthanee Hospital Public Company Limited NVDR has an Altman Z-Score of 2.50, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.